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Summary Group B Streptococcus (GBS) infection has long been recognized as a
frequent cause of morbidity and mortality in newborn infants. The purpose of this
study was to determine the colonization rate with GBS and the antibiotic susceptibil-
ity proﬁle in pregnant women attending Gynecological clinics in Egypt. One-hundred
and ﬁfty vaginal swabs were collected from pregnant women at 35—40 weeks of ges-
tation. In comparison to culture, direct latex agglutination testing revealed 100%
sensitivity and 93.75% speciﬁcity. Thirty-eight specimens (25.3%) were found to be
positive for GBS. Each isolate was tested for susceptibility to penicillin G, ampicillin,
cefotaxime, erythromycin, clindamycin and vancomycin. Erythromycin-resistant iso-
lates were further classiﬁed by double-disk method. All isolates were susceptible to
penicillin G, ampicillin and vancomycin. Resistance to cefotaxime was detected in
three isolates (7.89%). Five isolates (13.15%) were resistant to erythromycin and
nine isolates (23.68%) were resistant to clindamycin. Four (80%) isolates had consti-
tutive macrolide—lincosamide—StreptograminB resistance (cMLSBB) resistance and
one (20%) isolate had inducible resistance (iMLSB) resistance. GBS colonization was
found to be high in our region. Latex agglutination testing and Islam medium are
reliable methods to detect GBS in late pregnancy; however, latex agglutination test
is rapid and simpler. Penicillin G remains the ﬁrst choice antibiotic for treatment of
GBS infections.
© 2009 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University
for Health Sciences. All rights reserved.
∗ Corresponding author at: Tel.: +20 122712598/643917750; fax: +20 643230741.
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maginal carriage and antibiotic susceptibility proﬁle
ntroduction
treptococcus agalactiae or group B Streptococcus
GBS) infection has long been recognized as a fre-
uent cause of morbidity and mortality in newborn
nfants [1]. Life-threatening complications of GBS
acteremia, such as endocarditis, meningitis and
atal septicemia with multiorgan failure, have been
escribed over the last decades [2].
GBS is found in the vagina and/or rectum of
0—30% of pregnant women as normal ﬂora, and
nfants born to these women may develop disease
ue to exposure to bacteria before birth or dur-
ng the neonatal period [3]. These neonatal GBS
nfections are divided into early-onset infection and
ate-onset infection. Early-onset infection, which is
he most common type of neonatal GBS disease,
ccurs within the ﬁrst week of life, while late-onset
nfection occurs in infants between 1 week and 3
onths of age [4].
Maternal colonization with GBS is the most
redominant risk factor for the development of
nvasive neonatal GBS disease [5], since verti-
al transmission of GBS before or during delivery
an be found in the vast majority of all cases
5]. The revised Centers for Disease Control and
revention (CDC) guidelines issued in 2002 rec-
mmended a culture-based screening for vaginal
ectal/colonization with GBS for all pregnant
omen at 35—37 weeks of gestation for preven-
ion of early-onset GBS disease. If colonization is
etected, intrapartum antibiotic prophylaxis is rec-
mmended [6]. Implementation of these guidelines
as been associated with a falling incidence of
eonatal GBS disease in USA [7—9]. No epidemio-
ogical data has been published on the colonization
ate with GBS of pregnant women in Egypt. The
urpose of this study was to determine the cur-
ent colonization rate with GBS and the antibiotic
usceptibility proﬁle in our region.
aterials and methods
ulture and identiﬁcation procedures
ne-hundred and ﬁfty pregnant women (17—43
ears) at 35—40 weeks of gestation attending the
ynecological clinic at the Ismailia General Hospi-
al (400 beds) and the Gynecological Department
t the University Hospital of Suez Canal Univer-
ity (415 beds) from September 2007 to April 2008
ere enrolled in this study. One vaginal swab was
ollected from each patient with an informed con-






nd kept at 4 ◦C. Swabs were inoculated in selec-
ive enrichment broth medium (Todd-Hewitt broth
oxoid) supplemented with nalidixic acid 15g/ml
nd colistin 10g/ml). After 18—24 h incubation at
7 ◦C in 5% CO2, broths were subcultured onto Islam
edium (Oxoid). Islam media plates were exam-
ned for orange pigmented colonies after 24—48 h
f anaerobic incubation. In addition, latex aggluti-
ation testing (Streptococcal grouping kit, AVIPATH
TREP, Omega Diagnostics Ltd.) was performed
irectly on primary selective broth cultures. Posi-
ive selective broth cultures for GBS (either by latex
gglutination testing or Islam medium) were fur-
her conﬁrmed by the traditional culture method
hrough subculturing onto 5% columbia blood agar
oxoid) supplemented with nalidixic acid 15g/ml
nd colistin 10g/ml (CNA medium), incubated for
8—24 h at 37 ◦C in 5% CO2. Colonies on CNA plates
ere identiﬁed by Gram stain, hemolysis, cata-
ase, CAMP test (named after Christie, Atkins and
unch-Petersen), hippurate hydrolysis test, and
ile esculin hydrolysis test [10,11].
ntibiotic susceptibility testing and
acrolide resistance phenotypes
ach isolate was tested for susceptibility to peni-
illin G, ampicillin, cefotaxime, erythromycin,
lindamycin and vancomycin using disk diffu-
ion method according to CLSI (formerly NCCLS)
uidelines [12]. Erythromycin-resistant isolates
ere further classiﬁed as having cMLSBB (con-
titutive macrolide—lincosamide—StreptograminB
esistance), iMLSB (inducible resistance), or M phe-
otype (macrolide—StreptograminB resistance and




mong the 150 patients that were enrolled in the
tudy a total of 38 specimens (25.3%) were found
o be positive for GBS by Islam medium. The direct
atex agglutination testing on primary selective
roth cultures detected 45 (30%) positive speci-
ens.
All specimens found to be positive by culture onslam medium were also positive by latex agglutina-
ion testing. Among the 112 Islam medium negative
pecimens, 7 were positive by latex agglutina-
ion testing. It was noticed that all these seven

















































Streptococcus group B and group D. Presumptive
identiﬁcation of Enterococcus spp. was achieved
using bile esculin test. When these samples were
analysed by traditional culturing method, GBS
failed to be recovered from primary selective broth
cultures and were considered false positive by latex
agglutination testing. Thus latex agglutination test-
ing directly on primary selective broth cultures
revealed 100% sensitivity and 93.75% speciﬁcity.
Antibiotic susceptibility testing and
macrolide resistance phenotypes
All the 38 isolates were uniformly susceptible to
penicillin G, ampicillin and vancomycin. Resis-
tance to cefotaxime was detected in three isolates
(7.89%) while 1 isolate (2.63%) was interme-
diate. Five isolates (13.15%) were resistant to
erythromycin and three (7.89%) were interme-
diate. Nine isolates (23.68%) were resistant to
clindamycin.
Among the erythromycin resistance isolates, four
(80%) isolates had constitutive cMLSBB resistance
and one (20%) isolate had inducible iMLSB resis-
tance.
Discussion
In the present study, the prevalence of GBS in
Ismailia, Egypt was found to be 25.3%. Such ﬁnd-
ing was in accordance with studies from the United
States and Europe that reported colonization rates
between 6.5% and 36% [14—16,4]. Recent Arabian
studies showed similar colonization rates ranging
from 10.1% in United Arab Emirates [17], 16.4% in
Kuwait [18], 17% in Tunisia [19], and 27.6% in Saudi
Arabia [20]. This was consistent with a recent sur-
vey by Stoll and Schuchat [21] who demonstrated
that despite the geographical variations, GBS colo-
nization rates have similar ranges in developed and
developing countries. Different colonization rates
during pregnancy may also be attributed to mater-
nal age, parity, ethnicity, marital status, education,
smoking and frequent intercourse with multiple
partners [22]. According to Badri et al. [23] and
Philipson et al. [24] vaginorectal swabs increase the
GBS yield by 40—50%, however, vaginal swabs only
were involved in the present study and thus the
true burden of colonization was underestimated.
The GBS colonization rate might have been higher
reaching 38% if vaginorectal swabs were used. Con-
sidering many obstacles related to cultural believes
and ignorance with the importance of GBS screen-
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wabs or rectal swabs were hard to be obtained
lthough vaginal swabs are often taken as a part
f routine examination during pregnancy.
Screening for GBS directly on selective enrich-
ent broth cultures by using latex agglutination
esting revealed a sensitivity of 100% and speci-
city of 93.75%. Such sensitivity was higher than
hose reported by Guerrero et al. [25] and Park
t al. [26]. However, the demonstrated speciﬁcity
as quite similar to that reported by Poilane et al.
27]. The use of latex agglutination test directly on
rimary broth cultures provided detection of GBS
4—48 h sooner than the culture method using Islam
edium. Besides, latex agglutination test is sim-
le, rapid, easy to perform, and does not require
pecial equipments. In contrast to pigment-based
ulture method using Islam medium which may be
umbersome to use from the standpoint of requiring
naerobic culture conditions.
Concerning the seven GBS latex positive sam-
les with negative subcultures on Islam medium
r CNA medium, GBS failed to be recovered from
hese samples, suggesting the occurrence of a pos-
ible antagonistic phenomenon. Park et al. [26]
emonstrated that heavy growth of GBS usually
acked concomitant growth or had only very light
rowth of Enterococcus fecalis. Conversely, very
ight growth of GBS revealed heavy growth of E.
ecalis. Bourbeau et al. [28] had a similar expe-
ience when ﬁve of nine GBS specimens failed to
ultiply in selective enrichment broth. A possible
xplanation was suggested by Dunne and Holland-
taley [29], who noticed that certain strains of
BS appear to be suppressed by a moderate to
eavy growth of E. fecalis. Other explanations may
nclude presence of nonviable GBS that could be
etected by antigen-detection method but not by
ulture, as well as inability of culture to detect
ow bacterial numbers. Antibiotics and feminine
ygiene products have also shown to inhibit the
etection of GBS by culture but have no detrimen-
al effect on antigenic detection [30]. Inadequate
pecimen collection and transport from obstetri-
al clinics to the laboratory may have some effect
specially in case of light colonization [31,32].
Susceptibility testing revealed that GBS is
niformly susceptible to penicillin G, ampicillin
nd vancomycin. Most other studies have found
he same [33—36]. Penicillin G is the drug of
hoice when diagnosis is established. However,
n increased resistance to erythromycin and clin-
amycin, the drugs of choice for women with
erious penicillin allergy, has been observed. In
his regard, 13.15% of the tested GBS isolates
ere resistant to erythromycin and 23.68% to clin-














































[aginal carriage and antibiotic susceptibility proﬁle
he present study showed much lower resistance
ates to erythromycin and clindamycin than those
eported by Dunia et al. in Syria [37]. However, it
evealed higher resistance rates to these antibiotics
han those reported by Al-Seweih et al. in Kuwait
38]. In regard to recent studies from America and
urope, the present ﬁndings were consistent with
hose reported by Barbaros et al. in Turkey [39],
uch lower than those reported by DiPersio and
iPersio in USA [40] and higher than those reported
y Schoening et al. in Germany [41] and Figueira-
oelho et al. in Portugal [42].
The majority of the erythromycin-resistant iso-
ates showed cMLSB resistance and one had iMLSB
esistance. Quite similar distribution resistance
henotypes were described in studies from Portu-
al, France and Spain [42—45].
In conclusion, the vaginal GBS colonization rate
mong Egyptian women was found to be 25.3% and
hereby constitutes a group of womenwhose infants
re at great risk of GBS invasive infections. Latex
gglutination testing and Islam medium are reliable
ethods to detect GBS in late pregnancy; however,
atex agglutination test is rapid and simpler. Finally,
enicillin G remains the ﬁrst choice antibiotic for
he treatment of GBS infections. The majority of
he erythromycin-resistant isolates showed cMLSB
esistance. Continuous monitoring of the occur-
ence of resistance to antibiotics is essential, as the
mergence of resistant strains has become a grow-
ng concern on the therapy of GBS. The increasing
ates and continued spread of macrolide and lin-
osamide resistance in GBS have broad implications
or both prophylactic and empiric drug treatment
trategies.
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